Orion b News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.07.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
15.07.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
12.07.21	Orion recalls Multivita Forte dietary supplement from consumers (GlobeNewswire)
08.07.21	32,884 Orion Corporation A shares converted into B shares (GlobeNewswire)
04.07.21	Erste Schätzungen: Orion B zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
02.07.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
02.07.21	Orion publishes Half-Year Financial Report for January–June 2021 on Monday 19 July 2021 (GlobeNewswire)
30.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
29.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
28.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
23.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
23.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
21.06.21	Orion Animal Health’s Tessie® (tasipimidine) receives positive CVMP opinion (GlobeNewswire)
18.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
17.06.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
09.06.21	Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy (GlobeNewswire)
08.06.21	Orion and the Blood Service launch collaboration to develop new CAR T-cell cancer therapy (GlobeNewswire)
28.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
27.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
26.05.21	Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available (GlobeNewswire)
25.05.21	Orion to investigate possible sale of its pharmaceutical manufacturing plant in Kuopio, Finland (GlobeNewswire)
20.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
19.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
17.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
17.05.21	Orion Animal Health’s Bonqat® (pregabalin) receives positive CVMP opinion (GlobeNewswire)
11.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
05.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
05.05.21	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire)
04.05.21	Invitation to Orion’s Virtual Capital Markets Day on 26 May 2021 (GlobeNewswire)
27.04.21	CORRECTION: Composition of the Nomination Committee of Orion Corporation (GlobeNewswire)
27.04.21	Composition of the Nomination Committee of Orion Corporation (GlobeNewswire)
27.04.21	Orion Group Interim Report 1-3/2021 (GlobeNewswire)
27.04.21	Orion aims to achieve carbon neutrality by 2030 (GlobeNewswire)
25.04.21	Ausblick: Orion B legt Quartalsergebnis vor (finanzen.net)
12.04.21	Orion publishes Interim Report for January–March 2021 on Tuesday 27 April 2021 (GlobeNewswire)
12.04.21	Erste Schätzungen: Orion B gewährt Anlegern Blick in die Bücher (finanzen.net)
25.03.21	Orion Corporation: Organising meeting of the Board of Directors (GlobeNewswire)
25.03.21	Decisions taken by Orion Corporation’s Annual General Meeting on 25 March 2021 (GlobeNewswire)
15.03.21	Save the date – Orion’s Virtual Capital Markets Day on 26 May 2021 at 1.00 p.m. – 4.00 p.m. EEST (GlobeNewswire)
03.03.21	Change to the Notice of Orion Corporation’s Annual General Meeting (GlobeNewswire)
02.03.21	Orion Group Financial Statement documents 2020, Corporate Governance Statement and Remuneration Report published (GlobeNewswire)
01.03.21	Orion Corporation: Transfer of 99,768 own B shares on 1 March 2021 (GlobeNewswire)
09.02.21	Notice to the Annual General Meeting of Orion Corporation (GlobeNewswire)
09.02.21	Orion Group Financial Statement Release for 2020 (GlobeNewswire)
08.02.21	Orion and Bayer expand development program for darolutamide in prostate cancer (GlobeNewswire)
07.02.21	Ausblick: Orion B veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
02.02.21	83,386 Orion Corporation A shares converted into B shares (GlobeNewswire)
20.01.21	Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021 (GlobeNewswire)
18.01.21	Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania (GlobeNewswire)
12.01.21	Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2021 AGM of Orion Corporation (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Orion Corporation (New) (B)

Aktien Top/Flop

Meistgelesene Nachrichten